LENA CHANG: Open Payments
NPI 1326298290 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 10 payments from 5 companies in 2025. Trend: 2023 $1,745 · 2024 $1,502 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $692 |
| Novo Nordisk Inc | 2 | $242 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: General - Therapies, Wegovy, Ozempic, LEQVIO, TRELEGY ELLIPTA, CAMZYOS.
Industry payments across NY — which companies pay providers there.
